Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 371, Issue 23, Pages 2155-2166
Publisher
New England Journal of Medicine (NEJM/MMS)
Online
2014-11-17
DOI
10.1056/nejmoa1409312
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin–Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial
- (2014) Marc P. Bonaca et al. AMERICAN HEART JOURNAL
- Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trial
- (2014) W. Wijns et al. EUROPEAN HEART JOURNAL
- 2014 ESC/EACTS Guidelines on myocardial revascularization
- (2014) EUROPEAN HEART JOURNAL
- Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study
- (2013) Roxana Mehran et al. LANCET
- Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting
- (2012) Marco Valgimigli et al. CIRCULATION
- Heart Disease and Stroke Statistics—2013 Update
- (2012) Alan S. Go et al. CIRCULATION
- Primary Endpoint Results of the EVOLVE Trial
- (2012) Ian T. Meredith et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Clopidogrel Added to Aspirin in Patients with Recent Lacunar Stroke
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Standardized Bleeding Definitions for Cardiovascular Clinical Trials
- (2011) Roxana Mehran et al. CIRCULATION
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
- (2011) et al. CIRCULATION
- Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents
- (2011) Gregg W. Stone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Prospective Natural-History Study of Coronary Atherosclerosis
- (2011) Gregg W. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions
- (2010) Laura Mauri et al. AMERICAN HEART JOURNAL
- Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
- (2010) Seung-Jung Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence of Death and Acute Myocardial Infarction Associated With Stopping Clopidogrel After Acute Coronary Syndrome
- (2008) P. Michael Ho JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started